[Phrmacoactive coronary endoprothesis thrombosis after stopping antiplatelet treatment]

Y., Saidi; Fethi, Guesmi; M., Landolsi; S., Trabelsi; K., Khemiri; K., Ounalli; C., Dziri; M., Houissa

Y., Saidi; Fethi, Guesmi; M., Landolsi; S., Trabelsi; K., Khemiri; K., Ounalli; C., Dziri; M., Houissa.

Tunisie Medicale [La]. 2010; 88 (1): 63-64

in French | IMEMR | ID: emr-108834

Subject(s)

Humans; Male; Drug-Eluting Stents/adverse effects; Platelet Aggregation Inhibitors/administration & dosage; Angioplasty, Balloon, Coronary; Cholecystectomy, Laparoscopic/adverse effects; Ticlopidine/analogs & derivatives; Drug Therapy, Combination; Drug Administration Schedule; Aspirin/analogs & derivatives; Drug Administration Schedule

Search on Google

XML

Index: IMEMR (Eastern Mediterranean) Main subject: Ticlopidine / Drug Administration Schedule / Platelet Aggregation Inhibitors / Angioplasty, Balloon, Coronary / Aspirin / Cholecystectomy, Laparoscopic / Drug Therapy, Combination / Drug-Eluting Stents Limits: Humans / Male Language: French Journal: Tunisie Med. Year: 2010

Similar

MEDLINE

LILACS

LIS

Search on Google

XML